N-Phenyl-2-((4-phenyl-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide

Catalog No. :
ACUIMD950
CAS No. :
332385-31-6
Molecular Formula :
C21H17N5OS
Molecular Weight :
387.47

IUPAC Name:N-phenyl-2-((4-phenyl-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide

N-Phenyl-2-((4-phenyl-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$272.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Phenyl-2-((4-phenyl-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide
IUPAC NameN-phenyl-2-((4-phenyl-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide
MDL No.MFCD02049436
Molecular FormulaC21H17N5OS
Molecular Weight387.47
SMILESO=C(NC1=CC=CC=C1)CSC2=NN=C(C3=CC=CN=C3)N2C4=CC=CC=C4
InChI KeyDBDZIIKDPYLKRZ-UHFFFAOYSA-N
SynonymN-phenyl-2-{[4-phenyl-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide;Acetamide, N-phenyl-2-[[4-phenyl-5-(3-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]-
CAS No.332385-31-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUIMD950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUIMD950 route product structure diagram
    ACUIMD950332385-31-6
Inquiry

2. ACUIMD950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVRHZ791 route compound structure diagram
    ACVRHZ791587-65-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUIMD950 route product structure diagram
    ACUIMD950332385-31-6
Inquiry

Comments (0)